These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15040939)

  • 21. Recent advances in antifungal chemotherapy.
    Petrikkos G; Skiada A
    Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
    Metcalf SC; Dockrell DH
    J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.
    Slavin MA; Szer J; Grigg AP; Roberts AW; Seymour JF; Sasadeusz J; Thursky K; Chen SC; Morrissey CO; Heath CH; Sorrell T
    Intern Med J; 2004 Apr; 34(4):192-200. PubMed ID: 15086700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
    Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM;
    Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of the antifungal properties of allicin and its breakdown products--the possibility of a safe and effective antifungal prophylactic.
    Davis SR
    Mycoses; 2005 Mar; 48(2):95-100. PubMed ID: 15743425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
    Rijnders BJ; Cornelissen JJ; Slobbe L; Becker MJ; Doorduijn JK; Hop WC; Ruijgrok EJ; Löwenberg B; Vulto A; Lugtenburg PJ; de Marie S
    Clin Infect Dis; 2008 May; 46(9):1401-8. PubMed ID: 18419443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human mycoses and current antifungal therapy.
    Fromtling RA
    Drug News Perspect; 1998 Apr; 11(3):185-91. PubMed ID: 15616619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal models testing monotherapy versus combination antifungal therapy: lessons learned and future directions.
    Clemons KV; Stevens DA
    Curr Opin Infect Dis; 2006 Aug; 19(4):360-4. PubMed ID: 16804384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphotericin B lipid preparations: what are the differences?
    Adler-Moore JP; Proffitt RT
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():25-36. PubMed ID: 18430127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fungal infections in neonates: update on prevention and treatment.
    Kaufman DA
    Minerva Ginecol; 2007 Jun; 59(3):311-29. PubMed ID: 17576407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of life-threatening Candida peritonitis in a child with abdominal non-Hodgkin lymphoma using Efungumab and amphotericin B colloid dispersion.
    Krenova Z; Pavelka Z; Lokaj P; Skotakova J; Kocmanova I; Teyschl O; Kren L; Mudry P; Sterba J
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):128-30. PubMed ID: 20098335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomal amphotericin B: what is its role in 2008?
    Lanternier F; Lortholary O
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():71-83. PubMed ID: 18430132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy.
    Anaissie EJ
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):683-90. PubMed ID: 19041608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease.
    Cowen LE; Singh SD; Köhler JR; Collins C; Zaas AK; Schell WA; Aziz H; Mylonakis E; Perfect JR; Whitesell L; Lindquist S
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2818-23. PubMed ID: 19196973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress and prospects for targeting Hsp90 to treat fungal infections.
    Veri A; Cowen LE
    Parasitology; 2014 Aug; 141(9):1127-37. PubMed ID: 24560124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of antibodies against hsp90 in the treatment of fungal infections.
    Burnie J; Matthews R
    Drug News Perspect; 2003 May; 16(4):205-10. PubMed ID: 12942149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human monoclonal antibody-based therapy in the treatment of invasive candidiasis.
    Bugli F; Cacaci M; Martini C; Torelli R; Posteraro B; Sanguinetti M; Paroni Sterbini F
    Clin Dev Immunol; 2013; 2013():403121. PubMed ID: 23878583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.